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1. Introduction
Aflatoxins are a group of naturally occurring carcinogens that are known to contaminate dif‐
ferent human and animal food stuffs. Aflatoxins are poisonous by-products from soil-borne
fungus Aspergillus, which is responsible for the decomposition of plant materials [1-9]. The
occurrence of aflatoxins foods and food products vary with geographic location, agricultural
and agronomic practices. The susceptibility of food product to fungal attack occurs during
pre-harvest, transportation, storage, and processing of the foods [1, 2, 4, 6, 9, 10]. The prob‐
lem of aflatoxin contamination of the food products is a common problem in tropical and
subtropical regions of the world especially in the developing countries such as the sub-Sa‐
haran countries with poor practices and where the environmental conditions of warm tem‐
peratures and humidity favors the growth fungi [1, 2, 4, 6, 9, 10]. The various food products
contaminated with aflatoxins include cereals like maize, sorghum, pearl millet, rice and
wheat; oilseeds such as groundnut, soybean, sunflower and cotton; spices like chillies, black
pepper, coriander, turmeric and zinger; tree nuts such as almonds, pistachio, walnuts and
coconut; and milk and milk products [11]. The aflatoxins were initially isolated and identi‐
fied as the causative agent in Turkey X disease that caused necrosis of the liver in 1960 and
over 100,000 turkeys died in England and USA and the death was attributed to the con‐
sumption of a mould-contaminated peanut meal [2, 6, 9, 12, 13]. Very high concentrations of
aflatoxins are most often found in nutritive seeds such as maize, nuts and cereal grains in
Africa and rice in China and Southeast Asia [2, 6, 9, 12-14].
© 2013 Bbosa et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Difuranocoumarins Type of aflatoxin Aspergillus specie(s)
Difurocoumarocyclopenten
one series
Aflatoxin B1 (AFB1) A. flavus, A. arachidicola, A. bombycis, A.
minisclerotigenes, A. nomius, A. ochraceoroseus, A.
parasiticus, A. pseudotamarii, A. rambellii, Emericella
venezuelensis
Aflatoxin B2 (AFB2) A. arachidicola, A. flavus, A. minisclerotigenes, A.
nomius, A. parasiticus
Aflatoxin B2a (AFB2a) A. flavus
Aflatoxin M1 (AFM1) A. flavus, A. parasiticus; metabolite of aflatoxin B1 in
humans and animals and comes from a mother's milk
Aflatoxin M2 (AFM2) Metabolite of aflatoxin B2 in milk of cattle fed on
contaminated foods
Aflatoxin M2A (AFM2A) Metabolite of AFM2
Aflatoxicol (AFL) A. flavus, metabolite of AFB1
Aflatoxicol M1 Metabolite of AFM1
Difurocoumarolactone
series
Aflatoxin G1 (AFG1) A. arachidicola, A. flavus, A. minisclerotigenes, A.
nomius, A. Parasiticus
Aflatoxin G2 (AFG2) A. arachidicola, A. flavus, A. minisclerotigenes, A.
nomius, A. parasiticus
Aflatoxin G2A (AFG2A) Metabolite of AFG2
Aflatoxin GM1 (AFG1) A. flavus
Aflatoxin GM2 (AFGM2) Metabolite of AFG2
AFGM2A Metabolite of AFGM2
Aflatoxin B3 (AFB3) Aspergillus species not defined
Parasiticol (P) A. flavus
Aflatrem A. flavus, A. minisclerotigenes
Aspertoxin A. flavus
Aflatoxin Q1 (AFQ1) Major metabolite of AFB1 in in vitro liver preparations
of other higher vertebrates
Table 1. Summary of the major aflatoxins produced by the Aspergillus species of Moulds
Aflatoxins are a group of approximately 20 related fungal metabolites produced primarily
by the fungi Aspergillus flavus and A. parasiticus [15-18]. Aflatoxins belongs to a group of di‐
furanocoumarins that are classified into two broad groups according to their chemical struc‐
ture and they include the difurocoumarocyclopentenone series (AFB1, AFB2, AFB2A, AFM1,
AFM2, AFM2A and aflatoxicol) and the difurocoumarolactone series (AFG1, AFG2, AFG2A,
AFGM1, AFGM2, AFGM2A and AFB3) [15-19], (Table 1 and figure 1).
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Figure 1. Structures of the major aflatoxins B1, B2, G1, G2, M1, M2, B2A and G2A (Adopted from Reddy, 2012)[16]
The four major naturally known aflatoxins produced by the Aspergillus species of mold in‐
clude AFB1, AFB2, AFG1 and AFG2 where the “B” and “G” refer to the blue and green fluo‐
rescent colors produced under UV light on thin layer chromatography plates, while the
subscript numbers 1 and 2 indicate major and minor compounds, respectively. Whereas the
B designation of aflatoxins B1 and B2 result from the exhibition of blue fluorescence under
UV-light, while the G designation refers to the yellow-green fluorescence of the relevant
structures under UV-light [2, 6, 9, 12, 13]. The metabolic products of aflatoxins, M1 and M2
were first isolated from milk of lactating animals fed on Moldy grains contaminated with
aflatoxin hence, the M designation [2, 4]. These toxins have closely similar structures (Figure
1) and form a unique group of highly oxygenated, naturally occurring heterocyclic com‐
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pounds. Aflatoxins B2 and G2 were established as the dihydroxy derivatives of B1 and G1,
respectively. Whereas, aflatoxin M1 is 4-hydroxy aflatoxin B1 and aflatoxin M2 is 4-dihy‐
droxy aflatoxin B2. Of the four major aflatoxins (B1, B2, G1 and G2), G2 occurs in high quanti‐
ties though less toxic while AFB1 is the most toxic of all the aflatoxin. The World Health
Organization (WHO) classifies AFB1 as a class 1 carcinogen [4, 6, 9, 18]. The aflatoxins dis‐
play potency of toxicity, carcinogenicity, mutagenicity in the order of AFB1> AFG1> AFB2>
AFG2 [15-19]. The extent of toxicity depends on the organ affected especially the liver. The
lethal toxicity of aflatoxin B1 varies in different animals from extremely susceptible (Sheep,
Rat, Dog) to resistant species (Monkey, Chicken, Mouse). However, there are no toxicity in
humans though epidemiological data from studies in Africa, South Africa, South East Asia
and India implicate aflatoxins in the incidence of liver cancer especially the hepatobiliary
carcinoma and death of children due to malnutrition, kwashiorkor and marasmus [20, 21].
Aflatoxins have been associated with various diseases like aflatoxicosis and other health
problems in humans, livestock and domestic animals globally.
2. Absorption, distribution, metabolism, excretion and mechanisms of
action of aflatoxins
Aflatoxins are highly liposoluble compounds and are readily absorbed from the site of expo‐
sure usually through the gastrointestinal tract and respiratory tract into blood stream [22,
23]. Human and animals get exposed to aflatoxins by two major routes (a) direct ingestion of
aflatoxin-contaminated foods or ingestion of aflatoxins carried over from feed into milk and
milk products like cheese and powdered milk as well as other animal tissues mainly as
AFM1 [22](b) by inhalation of dust particles of aflatoxins especially AFB1 in contaminated
foods in industries and factories [24]. After entering the body, the aflatoxins are absorbed
across the cell membranes where they reach the blood circulation. They are distributed in
blood to different tissues and to the liver, the main organ of metabolism of xenobiotics. Afla‐
toxins are mainly metabolized by the liver to a reactive epoxide intermediate or hydroxylat‐
ed to become the less harmful aflatoxin M1 [25, 26]. In humans and susceptible animal
species, aflatoxins especially AFB1 are metabolized by cytochrome P450 (CYP450) microso‐
mal enzymes to aflatoxin-8,9-epoxide, a reactive form that binds to DNA and to albumin in
the blood serum, forming adducts and hence causing DNA damage [25, 26]. Various
CYP450 enzymes isoforms occur in the liver and they metabolize aflatoxin into a reactive
oxygen species (aflatoxin-8,9-epoxide), which may then bind to proteins and cause acute
toxicity (aflatoxicosis) or to DNA and induce liver cancer [25, 26]. The predominant human
CYP450 isoforms involved in human metabolism of AFB1 are CYP3A4 and CYP1A2. Both
enzymes catalyze the biotransformation of AFB1 to the highly reactive exo-8,9-epoxide of
AFB1[27]. CYP 1A2 is also capable of catalyzing the epoxidation of AFB1 to yield a high pro‐
portion of endo-epoxide and hydroxylation of AFB1 to form aflatoxin M1 (AFM1), which is a
poor substrate for epoxidation [27] and less potent than AFB1 [28]. This is generally consid‐
ered as the major detoxification metabolic pathway for aflatoxins. The CYP3A4 is the major
CYP450 enzyme responsible for activation of AFB1 into the epoxide form and also form
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AFQ1, a less toxic detoxification metabolite. The CYP3A5 metabolizes AFB1 mainly to the
exo-epoxide and some AFQ1 [29]. However, polymorphism studies with CYP3A5 have indi‐
cated that, this enzyme isoform is not expressed by most people especially in Africans [28].
Studies in Gambian children showed that aflatoxin cross the placenta and transported to the
fetus and the new born where they can cause detrimental effects [28]. The CYP3A7 is a ma‐
jor CYP450 enzyme isoform in human fetal liver and metabolizes AFB1 to the 8, 9- epoxide
that may cause fetal defects to the developing fetus [30].
The epoxidation of AFB1 to the exo-8, 9-epoxide is a critical step in the genotoxic pathway of
this carcinogen. The binding of AFB1 to DNA and DNA adduction by AFB1 exo-8,9 epoxide
has been reported to cause a functional changes of DNA conformation [31].The epoxide is
highly unstable and binds with high affinity to guanine bases in DNA to form afltoxin-N7-
guanine [32]. The aflatoxin-N7-guanine has been shown to be capable of forming guanine
(purine) to thymine (pyrimidine) transversion mutations in DNA and hence affecting the
p53 suppressor gene in the cell cycle [33, 34]. The p53 gene is important in preventing cell
cycle progression when there are DNA mutations, or signaling apoptosis. The mutations
have been reported to affect some base pair locations more than others especially in the
third base of codon 249 of the p53 gene in the region corresponding to the DNA binding do‐
main of the corresponding protein [13, 34]and this appears to be more susceptible to aflatox‐
in-mediated mutations than nearby bases [35]. AFB1 induces the transversion of base G to
base T in the third position of codon 249 and similar mutations have been observed in hepa‐
tocellular carcinoma (HCC) in high AFB1 contaminated food in regions in East Asia and Af‐
rica [34, 36, 37].
Epoxide hydrolase and glutathione-S-transferase (GST) are both involved in hepatic detoxi‐
fication of activated AFB1, but the GST-catalyzed conjugation of glutathione to AFB1-8,9-ep‐
oxides is thought to play the most important role in preventing epoxide binding to target
macromolecules like DNA and various cell proteins [38]. Glutathione pathway is reported to
play a vital role in the detoxification of AFB1 [39, 40]. The AFB1 8,9 exo and endoepoxides are
conjugated by glutathione to form AFB-mercapturate and the reaction is catalyzed by gluta‐
thione S-transferase (GST) [39, 40]. The glutathione-aflatoxin conjugate is transported from
the cells with an ATP-dependent multidrug-resistance protein through an accelerated proc‐
ess [39]. Despite a preference for conjugating the more mutagenic AFB1 exo-epoxide isomer,
the relatively low capacity for GST-catalyzed detoxification of bio-activated AFB1 in lung
may be an important factor in the susceptibility of the lung to AFB1 toxicity [4, 8, 41].The exo
and endo epoxide can also be converted non-enzymatically to AFB1-8,9-dihydrodiol which in
turn can slowly undergo a base-catalysed ring opening reaction to a dialdehyde phenolate
ion [27]. AFB1 dialdehyde can form Schiff bases with lysine residues in serum albumin form‐
ing aflatoxin-albumin complex [42]. Also the aflatoxin dialdehyde are reduced to a dialcohol
in a NADPH-dependent catalyzed reaction by aflatoxin aldehyde reductase (AFAR) [43].
However the guanine alkylation by aflatoxin B1 produces exo-8,9-epoxide which is the reac‐
tive form and a carcinogen to the liver and the reaction is more than 2000 times more effi‐
cient in DNA than in aqueous solution [44], (Figure 2).
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Figure 2. Aflatoxin disease pathways in humans (Adopted from Wu, 2010; Wu, 2011)[10, 26]
Figure 3. Various check points that can be damaged by binding of aflatoxins and AF-8,9-epoxide causing the deregu‐
lation of the cell cycle; P –prophase, M-Metaphase, A- Anaphase, T- Telophase, S- Synthetic DNA phase, G1 and G2 –
Gaps (growth phase) [47-49]
2.1. Effect of aflatoxins on mitochondrial DNA
The reactive aflatoxin-8,9-epoxide preferentially binds to mitochondrial DNA (mitDNA)
during hepatocarcinogenesis as compared to nuclear DNA that hinder ATP production and
FAD/NAD-linked enzymatic functions and this causes the disruption of mitochondrial func‐
tions in the various parts of the body that require production of energy in the form of ATP
[45]. Aflatoxin damage to mitochondria can lead to mitochondrial diseases and may be re‐
sponsible for aging mechanisms [45]. It is reported that certain mitochondrial diseases result
from the ability of the nucleus to detect energetic deficits in its area. The nucleus attempts to
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compensate for the ATP shortages by triggering the replication of any nearby mitochondria
but unfortunately, the response promotes replication of the very mitochondria that are caus‐
ing the local energy deficit hence aggravating the problem [46]. The AFB1 also binds to DNA
and cause structural DNA alterations that lead to gene mutations as well as changes in the
length of the telomeres and the check points in the cell cycle [47-49]. The binding of AFB1 to
DNA at the guanine base in liver cells corrupt the genetic code that regulates cell growth,
thereby leading to formation of tumors ([45-49]. The damage to mitDNA is caused by ad‐
duction and mutations of mitochondrial membranes leading to increased cell death (apopto‐
sis) as well as disruption of energy production (production of ATP) [46, 49, 50]. The reactive
aflatoxin-8, 9-epoxide can affect the mitotic (M) phase, growth process (G1 and G2 phase)
and DNA synthesis (S phase) in the cell cycle by disrupting the various check points that
regulate the cell cycle development and proliferation leading to deregulation of the cell and
hence cancer development [47-49], (Figure 3).
However in resistant rodents, their mitDNA is protected from aflatoxins from DNA adducts
that effect mitochondrial transcription and translation [46-49]. The mycotoxin alters energy-
linked functions of ADP phosphorylation and FAD- and NAD-linked oxidizing substrates
and α-ketoglutarate-succinate cytochrome reductases [46-49].
2.2. Effect of aflatoxins on mitochondrial structure
AFB causes ultrastuctural changes in mitochondria [46-49]and also induces mitochondrial
directed apoptosis thus reducing their function [20, 29, 48-51]. Also the aflatoxins may affect
the telomere length and the various check point in the cell cycle causing further damage to
the regulatory processes of the cell cycle [51]. Also the extent of aflatoxin binding to DNA
and its damage, the level of different proteins changes from cell cycle and apoptotic path‐
ways such as c-Myc, p53, pRb, Ras, protein kinase A (PKA), protein kinase C (PKC), Bcl-2,
NF-kB, CDK, cyclins and CKI contribute to the life or death decision making process that
may contribute to the deregulation of the cell proliferation leading to cancer development
[34, 48, 49](Figure 3).
2.3. Role of glutathione in detoxification of aflatoxins and their metabolites
However like in hepatic detoxification of aflatoxins and other chemicals, GSH act as antioxi‐
dant and has many functions in membrane maintenance and stability as well as in reducing
oxidative stress factors and the high reactive oxygen species (ROS) produced from the proc‐
ess of lipid peroxidation [38-41, 46, 52-56]. The increased depletion of GSH leads to abnor‐
mally high levels of ROS found in cells affected by aflatoxin due to uncoupling of metabolic
processes resulting from the lack of GSH for GSH-peroxidase catalysis of O2 to H2O2 leading
to lipid peroxidation and compromised cell membranes. Its reduction further enhances the
damage to critical cellular components (DNA, lipids, proteins) by the 8,9 epoxides. However
the most serious adverse effects of the AFB1-8,9-epoxide metabolite is that it reacts with
amino acids in DNA and forms an adduct [38-41, 46, 52-55]. The adduct are fairly resistant
to DNA repair processes and this causes gene mutation that leads to liver cancers especially
the hepatocellular carcinomas [38-41, 46, 52-55].
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2.4. The role of cytoplasmic reductase in detoxification of AFB1
Also in the hepatocytes, AFB1 are converted to other different classes of metabolites by cyto‐
plasmic reductase such as aflatoxicol and by microsomal mixed-function oxidase system to
form AFM1, AGFQ1, AFP1 and AFB1 -epoxide (the most toxic and carcinogenic derivative)
and these metabolites may be deposited in various body tissues as well as in edible animal
products [38-41, 46, 52-55]. These metabolites other than the AFB1 are less toxic and are con‐
jugated with other molecules that enhance their rapid elimination from the body [22]. The
metabolite AFQ1 has very little cancer-causing potential and they are usually excreted in
urine with little effect on the body.
2.5. Effect of aflatoxins on protein synthesis
The aflatoxin binds and interferes with enzymes and substrates that are needed in the initia‐
tion, transcription and translation processes involved in protein synthesis. They interacts of
with purines and purine nucleosides and impair the process of protein synthesis by forming
adducts with DNA, RNA and proteins [57]. Aflatoxin also inhibits RNA synthesis by interact‐
ing with the DNA-dependent RNA polymerase activity and thus causes degranulation of en‐
doplasmic reticulum. Also the reduction in protein content in body tissues like in skeletal
muscle, heart, liver and kidney could be due to increased liver and kidney necrosis [58]. AFB1 is
a potent mutagenic, carcinogenic, teratogenic, and immunosuppressive and all these may in‐
terfere with normal process of protein synthesis as well as inhibition of several metabolic sys‐
tems thus causing damages to various organs especially the liver, kidney and heart [59, 60].
2.6. Role of aflatoxins in cancer
Aflatoxins especially AFB1, AFG1 and AFM1 are the most toxic, naturally occurring carcino‐
gens known with AFB1 the most hepatocarcinogenic compound, causing various cancers of
the liver and other body organs in humans and animals [4, 14, 45, 61]. Aflatoxin’s cancer-
causing potential is due to its ability to produce altered forms of DNA adducts. The primary
disease associated with aflatoxin intake is hepatocellular carcinoma (HCC, or liver cancer).
This disease is the third-leading cause of cancer death globally [4, 45, 61], with about
550,000–600,000 new cases each year. The incidence of liver cancer has been consistently
higher in men than in women with a sex ratio ranging from 2 to 3 in most countries [9].
Eighty-three percent of these cancer deaths occur in East Asia and sub-Saharan Africa
[62-64]. Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide
with extremely poor prognosis. The majority of cases occur in south-east Asia and sub-Sa‐
haran Africa where the major risk factors of chronic infection with hepatitis B and C viruses
(HBV and HCV) as well as dietary exposure to aflatoxins are a problem [9, 25, 61, 65]. Afla‐
toxin B1, the most commonly occurring and potent of the aflatoxins is associated with a spe‐
cific AGG to AGT amino acid transversion mutation at codon 249 of the p53 gene in human
HCC, providing mechanistic support to a causal link between exposure and disease [25, 26,
66, 67]. Liver cancer has an increasing incidence that parallels the rise in chronic hepatitis B
(HBV) and hepatitis C (HCV) infection [25, 67, 68]. Chronic infection with hepatitis B virus
(HBV) or hepatitis C virus (HCV) can progress to advanced liver disease, including cirrhosis
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and hepatocellular carcinoma (HCC), a form of primary liver cancer [25, 61, 67, 68]. HCC is
the third leading cause of cancer-related mortality worldwide [69]. The data show that indi‐
viduals positive for the hepatitis B virus and exposed to aflatoxin in the diet are about 60
times of risk for developing hepato-biliary carcinoma or liver cancer [26, 66, 67] especially in
poor developing countries worldwide [67]. Reports have shown that a number of interac‐
tions exist between HBV and aflatoxins in development of hepatocellular carcinoma in hu‐
mans. They may include the fixation of AFB1-induced mutations in the presence of liver
regeneration and hyperplasia induced by chronic HBV infection, the predisposition of HBV-
infected hepatocytes to aflatoxin induced DNA damage, an increase in susceptibility to
chronic HBV infection in aflatoxin exposed individuals and oxidative stress exacerbated by
co-exposure to aflatoxins and chronic hepatitis infection [61](Figure 4).
In humans, epidemiological studies in Africa, Southeast Asia, USA and other countries of
the west where there is a high incidence of hepatocellular carcinoma, have revealed an asso‐
ciation between cancer incidence and the aflatoxin content of the diet [5, 6, 70]. Aflatoxin B1
(AFB1) is a major risk factor in the pathogenesis of liver cancer in Asia and sub-Saharan Afri‐
ca [71]. Aflatoxin B1 is a potent liver carcinogen in a variety of experimental animals. It caus‐
es liver tumours in mice, rats, fish, marmosets, tree shrews and monkeys following
administration by various routes. Types of cancers described in research animals include
hepatocellular carcinoma (rats) colon and kidney (rats), cholangiocellular cancer (hamsters),
lung adenomas (mice), and osteogenic sarcoma, adenocarcinoma of the gall bladder and car‐
cinoma of the pancreas (monkeys) [5, 6, 12, 70].
3. Health effects of aflatoxins on human and animals (Aflatoxicosis)
Aflatoxicosis is a condition caused by aflatoxins in both humans and animals. It occurs in
two general forms (1) the acute primary aflatoxicosisis produced when moderate to high
levels of aflatoxins are consumed. Specific acute episodes of disease may include hemor‐
rhage, acute liver damage, edema, alteration in digestion, absorption and/or metabolism of
nutrients, and possibly death [5, 6, 12, 69, 70]. Acute dietary exposure to AFB1 has been im‐
plicated in epidemics of acute hepatic injury [13, 72]. Evidence of acute aflatoxicosis in hu‐
mans has been reported worldwide especially in the third world countries like Taiwan,
Uganda, India, Kenya and many others [7]. (2) The chronic primary aflatoxicosis results
from ingestion of low to moderate levels of aflatoxins (USAID, 2012). The effects are usually
subclinical and difficult to recognize. Some of the common symptoms are impaired food
conversion and slower rates of growth with or without the production of an overt aflatoxin
syndrome [9]. The chronic forms of aflatoxicosis include (1) teratogenic effects associated
with congenital malformations (2) mutagenic effects where aflatoxins cause changes (muta‐
tions) in the genetic code, altering DNA and these changes can be chromosomal breaks, re‐
arrangement of chromosome pieces, gain or loss of entire chromosomes, or changes within a
gene (3) the carcinogenic effect in which the carcinogenic mechanisms have been identified
such as the genotoxic effect where the electrophilic carcinogens alter genes through interac‐
tion with DNA and thus becoming a potential for DNA damage and the genotoxic carcino‐
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gens that are sometimes effective after a single exposure, can act in a cumulative manner, or
act with other genotoxic carcinogens which affect the same organs [50, 60]. Chronic effects of
aflatoxin has been reported to impair the normal body immune function by either by reduc‐
ing phagocytic activity or reduce T cell number and function as observed immunological
suppression in animal model. Aflatoxins have also been reported to interfere with nutrition
in a dose response relationship between exposure to aflatoxin and rate of growth in infants
and children [4, 9, 20, 50, 60]. Aflatoxins also causes nutrient modification like vitamin A or
D in animal models and thus making them unavailable for the normal body physiology and
hence leads to nutritional deficiencies [7, 20].
The contamination of foods and feeds with aflatoxin can cause serious consequences in hu‐
man and animal health. It is estimated that more than 5 billion people in developing coun‐
tries worldwide are at risk of chronic aflatoxin exposure due to consumption of aflatoxin-
contaminated foods and of these more than 4 billion people develop aflatoxin related liver
cancer especially the hepatocellular carcinoma [64, 69, 73, 74]. Aflatoxin exposure is mainly a
problem in poor and developing countries with poor regulatory authorities in food process‐
ing and storage as well as with high levels of malnutrition. Aflatoxins have also been linked
with kwashiorkor and marasmus in most of the sub-Saharan countries in children [20].
Many people in these countries experience chronic aflatoxicosis associated with long-term
exposure to low to moderate levels of aflatoxin in the food supply chain. AFB1, AFB2 and
AFM have been detected in liver, gall bladder, spleen, heart, muscle and kidney [75]. Afla‐
toxin B1 exposure results in both steatosis and accumulation of fat and necrosis or cell death
of liver cells. The amount of aflatoxins consumed contributes to the mutagenic, carcinogenic,
teratogenic, and immunosuppressive health effects in the body. The adverse effect of afla‐
toxins in humans ranges from acute hepatic toxicity to chronic disease such as liver cancer,
haemorrhages, oedema, and even immediate death. Prolonged consumption of aflatoxins
has also been reported to cause impaired immune function and malnutrition and stunted
growth in children and a number of disabilities and death [7, 76, 77]. Human studies have
reported that aflatoxins cause an increase in circulating alpha tumor necrosing factor, sug‐
gesting that these mycotoxins are also immunotoxic in humans. Due to the aflatoxin body
immunosuppressant, it has been associated with HIV and tuberculosis [66, 67](Figure 2).
Aflatoxins also pose a threat to developing fetuses and they are transferred from mother to
infant in breast milk. Aflatoxins have been reported to be associated with a Reye-like Syn‐
drome in Thailand, New Zealand, Czechoslovakia, the United States, Malaysia, Venezuela,
and Europe [4, 50, 78].
All species of animals are susceptible to aflatoxicosis and the susceptibility of individual ani‐
mals to aflatoxicosis varies considerably depending on dose, duration of exposure, species,
age, sex and nutrition. AFB1, AFB2 and AFM have been detected in liver, gall bladder, spleen,
heart, muscle and kidney of growing swine when protein and protein-free portions of the diet
were separately fed [75]. Chronic exposure of aflatoxins to animals causes immunosuppres‐
sion and also interferes with protein metabolism and multiple micronutrients that are critical
to health due to adduct formation. These adduct are responsible for mutations, cancer, immu‐
nosuppression, lung injury and birth defects [46]. In animals, the aflatoxins cause liver dam‐
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age, decreased milk production, reduced reproductively and suppressed immunity in animals
consuming low dietary concentrations. The aflatoxicosis syndrome in animals may also be
characterized by vomiting,  abdominal  pain,  pulmonary oedema, convulsions,  coma, and
death with cerebral edema and fatty involvement of the liver, kidneys, and heart. In dairy and
beef cattle, the signs of acute toxicosis include anorexia, depression, dramatic drop in milk pro‐
duction, weight loss, lethargy, gastrointestinal dysfunctions such as ascitis, icterus, tenesmus,
abdominal pain, bloody diarrhoea, decreased feed intake and efficiency; weight loss, jaundice,
abortion, hepatoencephalopathy, blindness, walking in circles, ear twitching, frothy mouth,
photosensitization, bleeding and death [4, 6, 22, 79]. In poultry, beside inappetance, weight
loss, decreased egg production, leg and bone problems, poor pigmentation, fatty liver, kidney
dysfunction, bruising and death, suppression to natural immunity and susceptibility to para‐
sitic, bacterial and viral infections can occur [6, 22], (Figure 4).
Figure 4. Aflatoxin disease pathways in humans (Adopted from Wu, 2010; USAID, 2012; WHO, 2011; Wu and Tritsch‐
er, 2011) [7, 26, 80]
4. Biological effect of aflatoxins on the body organs and body systems
Aflatoxins have been reported to affect the various body organs like the liver, kidneys,
lungs, brain, testes and many endocrine and exocrine organs, the heart, skeletal muscles and
the different body systems.
4.1. Role of aflatoxins in hepatic injury and other body organs and tissues
Aflatoxins have been reported to cause liver cirrhosis as well as liver cancers [4, 6, 7, 26, 80].
Hepatic injury can be acute or chronic form caused by a variety of toxic agents like aflatox‐
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ins, chemicals and drugs, trauma and infectious agents [2, 4, 6, 7, 26, 61, 76, 80, 81]. The re‐
duced level of total protein is indicative of the toxic effect of AFB1 to the liver due to the
failure in synthesis of the proteins and kidney in which aflatoxins are known to impair pro‐
tein biosynthesis by forming adducts with DNA, RNA and proteins, inhibits RNA synthesis,
DNA-dependent RNA polymerase activity and causes degranulation of endoplasmic reticu‐
lum [58-60]. Acute hepatic injury due to aflatoxin causes a rise in serum enzymes including
aspartate aminotransferase, lactate dehydrogenase, glutamate dehyrogenase, gamma-gluta‐
myltransferase and alkaline phosphatase and bilirubin that reflect liver damage as well as
other biochemical changes such as proteinura, ketonuria, glycosuria and hematuria [4, 5,
40]. The other frequently used liver enzymes are the alkaline phosphatase (ALP) and Gam‐
ma-glutamyltransferase and gamma-glutamyltranspeptidase (GGT and GGTP) that indicate
obstruction to the biliary system, either within the liver or in the larger bile channels outside
the liver [9, 45, 61]. The presence of jaundice and neurological disorders due to brain dam‐
age leading to hepatic encephalopathy are associated with liver failure. Chronic liver failure
leads to accumulation of metabolites in circulation such as ammonia and fatty acids that
eventually lead to brain damage and hence hepatic encephalopathy [40, 82]. The liver failure
makes it unable to detoxify ammonia, the product of protein and amino acid metabolism
leading to hyperammonemia that may cross the blood brain barrier leading to increased
synthesis of glutamate neurotransmitters henceleading to cytotoxicity of the brain cells and
hence the hepatic encephalopathy [82-84]. AFB1 has been reported to cause pallor discolora‐
tion of liver and enlargement of liver and kidneys, congestion of liver parenchyma, cytoplas‐
mic vaculation or fatty change of hepatocytes, necrosis of hepatocytes and newly formed
bile ducts, mononuclear and heterophilic cell infiltration are reported in aflatoxin fed broiler
chicks [85]. It is also reported that there is a decrease in protein content in skeletal muscle,
heart, liver and kidney in aflatoxin-fed animals due to the AFB1’s potent mutagenic, carcino‐
genic, teratogenic, immunosuppressive and its ability to inhibits several metabolic systems
such as protein synthesis thus leading to liver, kidney and heart damage [58-60]. In chicken,
the activity of serum or plasma enzymes like the sorbitol dehydrogenase, glutamic dehydro‐
genase, lactate dehydrogenase, alkaline phosphatase, acid phosphatase, aspartate amino‐
transferase and alanine aminotransferase were reported to be increased in aflatoxicated
chickens [22].
4.2. Effect of aflatoxins on the central nervous system
In the brain or central nervous system, the neurons have a high metabolic rate but little ca‐
pacity for anaerobic metabolism and subsequently, inadequate oxygen flow to the brain kills
the neuronal brain cells within minutes. Some compounds damage neurons or neurotoxic
and thus inhibit their function. Mycotoxins especially aflatoxins and its metabolites and oth‐
er products such as the reactive oxygen species (ROS) like the AFB-8,9-epoxides may inter‐
fere with the normal functioning of the nerve cells by forming DNA adducts, protein
adducts, oxidative stress factors, mitochondrial directed apoptosis of the nerve cells as well
as inhibiting their synthesis of protein, RNA and DNA [40, 44, 47, 50, 52, 54]. Aflatoxins also
cause abnormalities in mitochondrial DNA, structure and function, including defective oxi‐
dative phosphorylation in the brain cells [29, 49, 50, 54]. The oxidative stress may result in
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damage to critical cellular macromolecules such as DNA, lipids and proteins. Cellular fatty
acids are readily oxidized by ROS to produce lipid peroxyl radicals which can subsequently
propagate into MDA that may interact with cellular DNA to cause DNA-MDA adduct that
may affect energy production in the brain [29, 49, 50, 54]. The role of ROS has been postulat‐
ed in the development of aging and chronic degenerative diseases, inflammatory diseases
and brain cancers [52]. Aflatoxins may also deplete the myelin sheath of the nerves, an im‐
portant substance that covers the nerves and hence become exposed to insults. Mycotoxins
especially aflatoxins have been reported to be toxic to various aspects of brain chemistry and
their function [4, 50, 82]. AFB1 also alters the levels of various biogenic amines (neurotrans‐
mitters) and their precursors in rat and mouse brains. Acute AFB1 treatment in experimental
animals has been reported to cause a decrease in regional brain acetylcholinesterase en‐
zymes that may affect the cognitive functions as well as memory and learning of the indi‐
vidual while chronic exposure increases adenohypophyseal acetylcholinesterase [24].
Aflatoxin causes a decrease in dopamine, serotonin and alterations in the levels of the pre‐
cursor’s tyrosine and tryptophan [86-88]. Deficiencies in these neurotransmitter lead to neu‐
rological symptoms such as neurocognitive decline and alteration of sleep cycle and
symptoms of brain damage like dullness, restlessness, muscle tremor, convulsions, loss of
memory, epilepsy, idiocy, loss of muscle coordination, and abnormal sensations [89, 90].
AFB1 has also been reported to increase the central and peripheral nervous system Na+/K+-
ATPase, β-glucuronidase and β-galactosidase while inhibiting the Mg2+-ATPse in experi‐
mental animals and this also is important in the normal functioning of the glutamate
neurotransmitter and their NMDA receptors [24, 53, 91-93]. The liver failure makes it unable
to detoxify ammonia, the product of protein and amino acid metabolism leading to hyper‐
ammonemia that may cross the blood brain barrier leading to increased synthesis of gluta‐
mate neurotransmitters hence leading to cytotoxicity of the brain cells and hence the hepatic
encephalopathy [82-84]. Toxic encephalopathy was originally described in children with
Reye’s syndrome associated with consumption of Aflatoxin B1 and/or salicylates [78] and
subsequently in cases of aflatoxicosis in canines and Chinese children were reported [94].
Aflatoxins also have been linked to Reye's syndrome that is characterized by symptoms of
encephalopathy and fatty degeneration of the viscera. It is a pediatric disease characterized
by cerebral edema and neuronal degeneration. Toxic encephalopathy due to aflatoxins in‐
volves multiple symptoms like loss of balance, recent memory decline, headaches, light‐
headedness, spaciness/disorientation, insomnia, loss of coordination [4, 18, 50, 82].
Aflatoxins have been reported to be associated with a Reye-like Syndrome in Thailand, New
Zealand, Czechoslovakia, the United States, Malaysia, Venezuela and Europe [4, 9, 24, 50,
78]. Aflatoxins especially AFB1 have been reported to cause tumors in both the central and
peripheral nervous system and several nonepithelial neurogenic tumors like the schwanno‐
mas, gliomas, meningiomas and granular cell tumors have been reported [24].
4.3. Effect of aflatoxins on the gastrointestinal tract (GIT)
The gastrointestinal tract (GIT) is the main route of entry of aflatoxins as a result of con‐
sumption of aflatoxin-contaminated foods especially AFB1. It is also the main route of excre‐
tion aflatoxin metabolites from the bile. The aflatoxins, metabolites and AF-8,9-epoxides
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have been reported to cause intestinal tumors especially the human colon cancers like colon
carcinomas and similar results have been reported in experimental animals [24]. Aflatoxins
have also been reported to cause serious acute effects on the GIT [95]. Aflatoxins have been
implicated as potential factors in the increased incidence of human gastrointestinal and hep‐
atic neoplasms in Africa, Philippines and China [22]. Aflatoxins have been reported to cause
digestive system effects such as diarrhea, vomiting, intestinal hemorrhage, and liver ne‐
crosis and fibrosis [89]. Aflatoxins have been reported also to damage the integrity of the
pancreas. In domestic animals, aflatoxins cause changes in the GIT physiology especially de‐
creased rumen motility and function in cows [24]. In birds, aflatoxins interfere with intesti‐
nal morphology, sialic acid production and apparent digestible energy [96].
4.4. Effect of aflatoxins on the respiratory system
Aflatoxins have reported to have serious acute effects on the respiratory systems [95].The res‐
piratory tract is the only organ system with vital functional elements in constant and direct
contact with the environment [97]. Many people working in food industries as their occupa‐
tional setting get exposed to aflatoxins especially AFB1 when they inhale aflatoxin-contaminat‐
ed dusts like during grain shelling and processing and have been reported to have a higher
incidences of upper respiratory tract and lung cancers [24, 95]. In experimental animals, AFB1
was reported to induce 100% pulmonary adenomas. In the respiratory tract, aflatoxins may al‐
so be converted to active metabolites like in the nasal mucosa [23]. It is also reported that the in‐
tranasal administration of AFB1 lead to formation of tissue-bound metabolites in subtentacular
cells, bowman's glands and in neuronal cells in the olfactory mucosa but there is no evidence
that AFB1 may induce tumours in olfactory bulbs [98]. Epoxide hydrolase and glutathione-S-
transferase (GST) are both involved in hepatic detoxification of activated AFB1 but the GST-cat‐
alyzed conjugation of glutathione to AFB1-8,9-epoxides is thought to play more important role
in preventing epoxide binding to target macromolecules [23, 89, 99]. However, the low capaci‐
ty for GST-catalyzed detoxification of bio-activated AFB1 in lung may be an important factor in
the susceptibility of the lung to AFB1 toxicity ([41]. Nose-only inhalation exposure of rats to
AFB1 aerosols suppressed alveolar macrophage (AM). Intratracheal administration of AFB1 al‐
so suppressed the release of tumor necrosis factor-alpha from AMs and impaired systemic in‐
nate  and  acquired  immune  defenses  as  well  as  suppression  of  peritoneal  macrophage
phagocytosis and the primary splenic antibody response thus leading to suppression of respi‐
ratory tract defenses system [99].
4.5. Effect of aflatoxins on the cardiovascular system, blood and blood cells
Aflatoxins have reported to have serious acute effects on the cardiovascular systems includ‐
ing vascular fragility and hemorrhaging in tissues [58, 89, 95] as well as heart damage and
teratogenic effects [59, 60]. It is reported that there is a decrease in protein content of the
muscles of these tissues and organs as well as inhibition of their metabolic processes attrib‐
utable by the aflatoxin consumption of contaminated foods [59, 60].
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4.6. Effect of aflatoxins on the blood and blood cells
The aflatoxins and its metabolites as well as the generated reactive oxygen species(ROS) has
been reported to have a deleterious effects on the bone and blood cells as well as induction
of cancers on the hemopoietic system in bone marrow and lymphoid organs where blood,
blood cells and blood components are produced [52]. The blood system can be damaged by
agents that affect blood cell production (bone marrow), the components of blood (platelets,
red blood cells, and white blood cells), or the oxygen-carrying capacity of red blood cells or
impair blood clotting and their poor growth rates. Oxidative damage by the AFB1 on human
lymphocytes has been reported [100] and significant declines in both the proportion of pe‐
ripheral blood lymphocytes and in the percentages of ANAE-positive peripheral blood lym‐
phocytes (T-lymphocytes) in a dose dependent manner has been observed [101]. Aflatoxins
have been linked to anemia in pregnancy [7, 102] and alterations in erythrocytes during in‐
duced chronic aflatoxicosis in rabbit also have been reported [103, 104]. Aflatoxin causes
hematopietic suppression and anemia, decrease in total erythrocytes, packed-cell volume
and hemoglobin [16] as well as toxicity to red blood cells [103]. Aflatoxin is known to pro‐
duce hemolytic anemia by decreasing the circulating mature erythrocytes [104]and conse‐
quently the spleen appear congested because of an unusually high concentration of
inorganic iron and debris from the circulation [103, 104]. In birds, AFB1 is reported to causes
hematological changes [105]. Aflatoxicosis has been reported to cause lymphocytopenia and
monocytopenia and increased percentage of neutrophil counts [106]. In cattle, aflatoxins are
reported to cause blood coagulation defects that may involve impairment of prothrombin,
factors VII and X and possibly factor IX and similar effects are reported in dogs [5]. General‐
ly aflatoxins have been reported to depress growth and alter many aspects of humoral and
cellular immunity and thus affecting the hematological parameters [101, 107].
4.7. Effect of aflatoxins on the urinary system
The kidney is susceptible to many toxic agents due to the high amount of blood it receives
and about 20-25% of blood that flows in at rest coupled with the large amounts of circulat‐
ing toxicants that reach the kidneys [89]. The kidneys also have high oxygen and nutrient
requirements because of their workload and therefore filters one-third of the blood reaching
them and reabsorb 98-99% of the salt and water. Different parts of the nephrone are exposed
to aflatoxins especially the AFB1 and its metabolites leading to nephrotoxicity before it is ex‐
creted in the urine [24, 58]. The aflatoxin induced reduction in protein content has been re‐
ported to be due to increased necrosis of the kidney [58-60, 90]. AFB1 has been reported to
cause kidney tumors in experimental animals and a mixture of AFB and AFG was observed
to cause renal and hepatic tumors in 80% of hamsters [24]. There were also renal lesions
with features of megalocytosis in the proximal renal tubules. In Africa, birds exposed to
AFB1 were reported to develop fatty and hemorrhagic kidney syndrome, thickening of the
glomerular basement membrane, abnormal development of glomerular epithelial cells and
degenerative changes in renal tubular cells, congestion and parenchyma hemorrhage [24,
85]. In other animals, there was a reduction in the glomerular filtration rate, glucose reab‐
sorption and tubular transport of electrolytes and organic anions, reduced activities of renal
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glutamate-oxaloacetate and pyruvate transaminases and alkaline phosphatase in rats attrib‐
uted to by the aflatoxins and their metabolites as well as the generated ROS. There was in‐
duced aggregation and loss of chromatin, mitochondrial degeneration and loss of microvilli
induced by AFB1 in cultured kidney cell lines [24, 85].
4.8. Effect of aflatoxins on the endocrine system
Aflatoxin especially AFB has been reported to interfere with the functioning of the various en‐
docrine gland by disrupting the enzymes and their substrates that are responsible for the syn‐
thesis of the various hormones. Aflatoxins and their metabolites as well as the generated ROS
have been reported to cause various cancers in different endocrine glands like pituitary gland,
granulosa cell tumors of the ovary and adenomas and adenocarcinomas of the adrenal gland,
kidneys, thyroid gland, ovaries, testes, thyroid gland, parathyroid glands and endocrine pan‐
creas [4, 90, 108]. The plasma testosterone and luteinizing hormone (LH) concentrations have
been reported to reduce in aflatoxin-fed birds [90]. In laboratory animals, aflatoxin causes de‐
layed maturation of both males and females [4, 22, 90, 109]. Aflatoxicosis in white leghorn
males chicken decreased feed consumption, body weight, testes weight and semen volume
(Sharlin et al., 1980) and decreased plasma testosterone values [22].
4.9. Effect of aflatoxins on the reproductive system
In humans exposed to chronic aflatoxin-contaminated foods, it has been reported that high‐
er concentrations of aflatoxins occur in the semen of infertile men [3]. It is also associated
with low birth weight, a risk factor for jaundice in infants as well as presence of AFM in ma‐
ternal breast milk where it can cause deleterious effect in the newborns [102]. In Nigeria,
about 37% of the infertile men had aflatoxin in their blood and semen hence contributing to
the incidence of infertility in Nigerians [110]. Experimental results indicate that certain
agents like aflatoxins can interfere with the reproductive capabilities of sexes, causing sterili‐
ty, infertility, and abnormal sperm, low sperm count, and/or affect hormone activity in ani‐
mals. Aflatoxins have been reported to disrupt the reproductive system in both male and
female animals after ingestion of aflatoxin-contaminated foods. Aflatoxins also cause patho‐
logical alterations in the form of coagulative necrosis especially in the growing and mature
follicles and decrease in number and size of graffian and growing follicles with increased
number of atretic follicles and small areas of degenerative changes in experimental animals
[111]. AFB1 has been reported to have a deleterious effect on the reproductive capacity of
laboratory and domestic female animals where they cause reductions in ovarian and uterine
sizes, increases fetal resorption, implantation loss and intra-uterine death in the aflatoxin ex‐
posed female rats [111]. They also cause a reduction in the primary spermatocytes and sper‐
matids [112] and affect the morphology of the sperm cells produced [113]. Stillbirths were
reported in the 15th to the 18th days of pregnancy in rats [108]. The levels of plasma testos‐
terone, plasma 5a-DHT and absolute and relative testes weights were reported in experi‐
mental animals of aflatoxin-treated males remained low in all age groups and a delay in the
onset of sexual maturation during aflatoxicosis [114]. In cows, aflatoxins affected the repro‐
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ductive system by causing abortion, the birth of weak, deformed calves, reduced fertility
due to reduced vitamin A levels [109]. The teratogenic effects of AFB1 were described as en‐
larged eye sockets and enlarged liver of embryos [60]. In poultry, AFB1 cause a reduction in
semen volume, testes weight, spermatocrit and plasma testosterone as well as a reduction in
egg output [24].
5. Effect of aflatoxins on the immune system
Chronic consumption of aflatoxin-contaminated foods has been reported to cause immuno‐
suppression in both humans and animals worldwide [7, 89]. In human, aflatoxins affect both
the cellular and humoral immune responses where they alter immunological parameters in
participants with high AFB1 levels resulting in impairments in cellular immunity hence de‐
creasing the host resistance to infections [115-117]. Aflatoxin exposure has been shown to
cause immune suppression, particularly in cell-mediated responses [115-117]. Chronic expo‐
sures of the individual to aflatoxins depress the phagocytic efficiency of the phagocytes and
the delayed hypersensitivity reactions in birds [24]. Aflatoxins also deplete the cell popula‐
tions of the thymus; reduce the bone marrow and the red and white blood cells count, mac‐
rophage numbers and the phagocytic activity of the cells [24]. It also depresses the T-cell-
dependent functions of splenic lymphocytes in mice. The natural killer cell function of the
peripheral blood lymphocytes are also affected by aflatoxins especially AFB1 [24]. A reduc‐
tion in the leukocyte immunophenotypes in peripheral blood, CD4+ T cell proliferative re‐
sponse, CD4+ T and CD8+ T cell cytokine profiles and monocyte phagocytic activity were
reported. Children in developing countries appear to be naturally exposed to aflatoxin
through their diet at levels that compromise the immune system. In general, the proportion
of childhood growth stunting is directly correlated with the proportion of the population
living below the national poverty line and is inversely correlated with gross domestic prod‐
uct per capita [7, 45]. As is the case with liver cancer, childhood stunting is prominent in re‐
gions such as Southeast Asia and Sub-Saharan Africa, where aflatoxin exposure through
consuming contaminated food is common [7, 45]. It has been reported that the immunosup‐
pression and nutritional effects of chronic aflatoxin exposure may be linked to the high
prevalence of HIV in Southern Africa [7, 74, 118, 119]. The CD4 proteins that have been
weakened by aflatoxin exposure have been reported to correlate positively with HIV infec‐
tion [116]. Also high aflatoxin levels have been reported to increase risk of developing tuber‐
culosis in HIV positive individuals. Persons who are exposed to aflatoxin and are HIV
positive have decreased plasma vitamin A and vitamin E in the blood, although there was
no interaction detected between aflatoxin and HIV infection [120]. HIV infection is likely to
increase aflatoxin exposure by two possible routes: (1) HIV infection decreases the levels of
antioxidant nutrients that promote the detoxification of aflatoxin, or (2) the high degree of
co-infection of HIV-infected people with hepatitis B also increases the biological exposure to
aflatoxin [7, 118, 119]. Aflatoxin induce immunosuppression and increases susceptibility of
toxicated birds and animals to bacterial, viral and parasitic infections [58]. It also affects the
lymphoid follicles of caecum thus depleting the lymphocytes that may contribute to the ob‐
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served immunosuppression [117]. Aflatoxin decreases the concentrations of immunoglobu‐
lins IgM, IgG and IgA in birds as well as decrease complement activity in chickens [22, 121].
The low dose of AFB1 slightly decrease both mRNA and protein levels of lymphocytic IL-2,
IFNγ and it preferentially affects macrophage functions as well as IL-1α, IL-6 and TNF pro‐
duction by these cells [121, 122]. Aflatoxin suppression of the immune system therefore sub‐
jects the individual to high risk of susceptible to infectious diseases like parasitic, bacterial
and viral infections [123].
6. Conclusion
Chronic consumption of aflatoxin-contaminated foods is a common problem in both hu‐
mans and animals worldwide especially in poor developing nations of south East Asia and
sub-Saharan Africa where there is poor food harvesting, processing and storage of food and
food products thus allowing the growth of mold on them. Aflatoxins, their metabolites, the
aflatoxin-8,9-epoxide and the generated ROS causes deleterious effects on the various body
organs and body systems including the development of cancers especially the liver cancer
mainly due to AFB1 exposure. Aflatoxins are also responsible for the suppression of both the
humoral and cell-mediated immunity and thus making individuals susceptible to infectious
diseases. Aflatoxins also responsible for the malabsorption of various nutrients thus leading
to nutritional deficiencies, impaired immune function, malnutrition and stunted growth and
hence the development of kwashiorkor and marasmus in infants. Aflatoxins also can affect
almost all the different body systems and hence the health of the affected individuals espe‐
cially in poor developing nations of south East Asia and sub-saharan Africa where there is
poor food harvesting, processing and storage thus allowing the growth of mold on them.
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